PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)

The study involved the group of patients (n = 40) with psychotic disorders who used synthetic cannabinoids (spice). Among the psychotic disorders according to ICD-10 we allocated intoxication delirium (F12.03; 35 %), schizophreniform disorder (F12.50; 60 %), disorder with predominantly manic psychot...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: L. A. Ivanova, T. V. Terskikh, T. V. Tarasenko, L. V. Ivanova
Formato: article
Lenguaje:RU
Publicado: Scientific Сentre for Family Health and Human Reproduction Problems 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/aa9b126a2898407c98d0c842d2ba8b4f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aa9b126a2898407c98d0c842d2ba8b4f
record_format dspace
spelling oai:doaj.org-article:aa9b126a2898407c98d0c842d2ba8b4f2021-11-23T06:14:37ZPSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)2541-94202587-959610.12737/article_59a614f6883957.55938557https://doaj.org/article/aa9b126a2898407c98d0c842d2ba8b4f2017-04-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/610https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The study involved the group of patients (n = 40) with psychotic disorders who used synthetic cannabinoids (spice). Among the psychotic disorders according to ICD-10 we allocated intoxication delirium (F12.03; 35 %), schizophreniform disorder (F12.50; 60 %), disorder with predominantly manic psychotic symptoms (F12.55; 5 %). The average age of patients was 25.2 ± 4.4 years. Hereditary aggravation in patients who consume synthetic cannabinoids was presented by alcoholism and substance abuse (20 %), affective disorders (7.5 %), schizophrenia (5 %); personality disorders (10 %); suicides (2.5 %). The group of patients with intoxication with delirium had significantly higher frequency of family history of alcoholism and addiction to psychoactive substances compared with patients with schizophreniform disorder (p < 0.02). Clinic intoxication delirium was characterized by disturbance of consciousness (delirium, twilight) lasting from several hours to 2-3 days, psychomotor agitation, aggression, shouting certain phrases and words, anxiety, fear, visual hallucinations. In patients with acute schizophreniform disorder (24 patients; 60 %) symptoms consisted of a dominant affect (depressive, or mixed), productive psychopathological symptoms within the list of F20 headings of ICD-10. Productive syndromes were limited to verbal hallucinosis (true or its limiting variants) in the form of voiced (which discuss the patient's behavior, threaten him/her with death, offer advice), reference of persecutory delusion. The coming out of a psychotic state was characterized by short-term postpsychotic depression. Patients received detoxification therapy and also combined psychopharmacotherapy with the use of antipsychotics, antidepressants, tranquilizers, normotymics, nootropics.L. A. IvanovaT. V. TerskikhT. V. TarasenkoL. V. IvanovaScientific Сentre for Family Health and Human Reproduction Problemsarticleacute psychosissynthetic cannabinoids (spice)ScienceQRUActa Biomedica Scientifica, Vol 2, Iss 2, Pp 14-17 (2017)
institution DOAJ
collection DOAJ
language RU
topic acute psychosis
synthetic cannabinoids (spice)
Science
Q
spellingShingle acute psychosis
synthetic cannabinoids (spice)
Science
Q
L. A. Ivanova
T. V. Terskikh
T. V. Tarasenko
L. V. Ivanova
PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)
description The study involved the group of patients (n = 40) with psychotic disorders who used synthetic cannabinoids (spice). Among the psychotic disorders according to ICD-10 we allocated intoxication delirium (F12.03; 35 %), schizophreniform disorder (F12.50; 60 %), disorder with predominantly manic psychotic symptoms (F12.55; 5 %). The average age of patients was 25.2 ± 4.4 years. Hereditary aggravation in patients who consume synthetic cannabinoids was presented by alcoholism and substance abuse (20 %), affective disorders (7.5 %), schizophrenia (5 %); personality disorders (10 %); suicides (2.5 %). The group of patients with intoxication with delirium had significantly higher frequency of family history of alcoholism and addiction to psychoactive substances compared with patients with schizophreniform disorder (p < 0.02). Clinic intoxication delirium was characterized by disturbance of consciousness (delirium, twilight) lasting from several hours to 2-3 days, psychomotor agitation, aggression, shouting certain phrases and words, anxiety, fear, visual hallucinations. In patients with acute schizophreniform disorder (24 patients; 60 %) symptoms consisted of a dominant affect (depressive, or mixed), productive psychopathological symptoms within the list of F20 headings of ICD-10. Productive syndromes were limited to verbal hallucinosis (true or its limiting variants) in the form of voiced (which discuss the patient's behavior, threaten him/her with death, offer advice), reference of persecutory delusion. The coming out of a psychotic state was characterized by short-term postpsychotic depression. Patients received detoxification therapy and also combined psychopharmacotherapy with the use of antipsychotics, antidepressants, tranquilizers, normotymics, nootropics.
format article
author L. A. Ivanova
T. V. Terskikh
T. V. Tarasenko
L. V. Ivanova
author_facet L. A. Ivanova
T. V. Terskikh
T. V. Tarasenko
L. V. Ivanova
author_sort L. A. Ivanova
title PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)
title_short PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)
title_full PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)
title_fullStr PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)
title_full_unstemmed PSYCHOTIC DISORDERS IN PEOPLE USING SYNTHETIC CANNABINOIDS (SPICE)
title_sort psychotic disorders in people using synthetic cannabinoids (spice)
publisher Scientific Сentre for Family Health and Human Reproduction Problems
publishDate 2017
url https://doaj.org/article/aa9b126a2898407c98d0c842d2ba8b4f
work_keys_str_mv AT laivanova psychoticdisordersinpeopleusingsyntheticcannabinoidsspice
AT tvterskikh psychoticdisordersinpeopleusingsyntheticcannabinoidsspice
AT tvtarasenko psychoticdisordersinpeopleusingsyntheticcannabinoidsspice
AT lvivanova psychoticdisordersinpeopleusingsyntheticcannabinoidsspice
_version_ 1718417025906245632